By: SWOG Cancer Research Network From: medicalxpress.com Researchers with the SWOG Cancer Research Network have found that patients with metastatic hormone receptor-positive breast cancer who have low activity levels of the enzyme sTK1 in their blood serum at the start of anti-estrogen treatment live longer and go longer without their disease progressing than patients with high levels. The results suggest …
Mutations can reduce effect of hormonal treatment in early breast cancer
Source: Lund University From: eurekalert.org A small proportion of women who receive anti-estrogen treatment after breast cancer surgery have worse outcomes. This is associated with mutations in the estrogen receptor gene, according to a study from Lund University now published in JNCI Cancer Spectrum. “If our results are confirmed in further studies, it would be relevant to screen for these …